Synlett 2011(3): 357-360  
DOI: 10.1055/s-0030-1259508
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

Mild Conversion of Esters Lacking Acidic α-Hydrogens into Amides via Samarium(III) Tris[hexamethyldisilazide] and Amines

James B. Campbell*, Richard B. Sparks, Robert F. Dedinas
Lead Generation Department, CNS Discovery, AstraZeneca Pharmaceuticals, Wilmington, DE 19850-5437, USA
Fax: +1(302)8851453; e-Mail: campbelljim.jbc@gmail.com;
Further Information

Publication History

Received 22 October 2010
Publication Date:
25 January 2011 (online)

Abstract

Samarium(III) tris[hexamethyldisilazide] (Sm[(Me3Si)2N]3 = Sm[HMDS]3) promotes the direct conversion of an ester admixed with an amine into the corresponding carboxamide under exceptionally mild conditions (≤0 ˚C) and in high yields. Only a slight excess of amine and the lanthanide complex are required to effect complete conversion of the ester into the amide. Esters with acidic α-hydrogens undergo a competing Claisen-like condensation along with the desired conversion into amides.

    References

  • 1 Basha A. Lipton M. Weinreb SM. Tetrahedron Lett.  1977,  18:  4171 
  • 2 Levin JI. Turos E. Weinreb SM. Synth. Commun.  1982,  12:  989 
  • 3a Zhou P. Natale NR. Bioorg. Med. Chem. Lett.  1997,  7:  2455 
  • 3b Gajewski MP. Beall H. Schnieder M. Stranahan SM. Mosher MD. Rider KC. Natale NR. Bioorg. Med. Chem. Lett.  2009,  19:  4067 
  • 4a Wang WB. Roskamp EJ. J. Org. Chem.  1992,  57:  6101 
  • 4b Wang WB. Restituyo JA. Roskamp EJ. Tetrahedron Lett.  1993,  34:  7217 
  • 4c Smith LA. Wang WB. Barnell-Curty C. Roskamp EJ. Synlett  1993,  850 
  • 5 Yoon NM. Sim TB. Synlett  1994,  827 
  • 6 Bradley DC. Ghotra J. Hart FA. J. Chem. Soc., Dalton Trans.  1973,  1021 
  • 7 Jingqing R. Guangxian X. Sci. Sin., Ser. B  1987,  30:  337 
  • 8 Tsay C. Mankad NP. Peters JC. J. Am. Chem. Soc.  2010,  132:  13975 
  • 9 Bochkarev MN. Fedorova EA. Radkov YF. Khorshev SY. Kalina GS. Razuvaev GA.
    J. Organomet. Chem.  1983,  258:  C29 
  • 10 Bradley DC. Ghotra J. Hart FA. Hursthouse MB. Raithby PR. J. Chem. Soc., Dalton Trans.  1977,  1166 
  • 12a

    Preparation of anhyd lanthanide halides can be capricious as cited in ref. 12b. We found no difference in reactivity of the Ln[HMDS]3 complexes using lanthanide chlorides prepared by the Taylor procedure compared with using salts treated by drying of the commercially available LnCl3×7H2O salts under high vacuum at 140 ˚C overnight

  • 12b Taylor MD. Chem. Rev.  1962,  62:  503 
  • 13 Lanthanide triflates have been reported to promote the addition of amines to nitriles. See: Forsberg JH. Spaziano VT. Balasubramanian TM. Liu GK. Kinsley SA. Duckworth CA. Poteruca JJ. Brown PS. Miller JL. J. Org. Chem.  1987,  52:  1017 
  • 14 Sasai H. Arai S. Shibasaki M. J. Org. Chem.  1994,  59:  2661 
  • 15 LeRoux E. Liang Y. Storz MP. Anwander R. J. Am. Chem. Soc.  2010,  132:  16368 
  • 16 Johnson CD. Acc. Chem. Res.  1993,  26:  476 
  • 17a Burgi HB. Dunitz JP. Lehn JM. Wipff G. Tetrahedron  1974,  30:  1563 
  • 17b Bartlett GJ. Choudary A. Raines RT. Woolfson DN. Nat. Chem. Biol.  2010,  6:  615 
  • 20a Ren W. Yamane M. J. Org. Chem.  2010,  75:  3017 
  • 20b Li J. Xu F. Zhang Y. Shen Q. J. Org. Chem.  2009,  74:  2575 
  • 20c Tillack A. Rudloff I. Beller M. Eur. J. Org. Chem.  2001,  523 
  • 20d Deguest G. Devineau A. Bischoff L. Fruit C. Marsais F. Org. Lett.  2006,  8:  5889 
11

The lanthanide reagents were prepared according to the procedure of Bradley et al.6 Briefly, to a suspension of anhyd lanthanum chloride¹² in THF at r.t. was added dropwise 3 equiv of LiHMDS (Aldrich) as a 1.0 M solution in THF. Following completion of the addition, the mixture was warmed to 50 ¡C for 15 min and then cooled to the prescribed temperature for use in the amidation reactions. Other lanthanide HMDS complexes were prepared by an analogous procedure.

18

Procedure for Conversion of Esters into Amides Using Sm[HMDS] 3 Synthesis of Amide 4a Anhyd samarium chloride (0.280 g, 0.73 mmol) was dried under high vacuum at 140 ˚C for 15 h, then cooled to ambient temperature under argon. The residue was suspended in anhyd THF (4 mL) and LiHMDS (2.2 mL of a 1.0 M solution in THF, 2.20 mmol) was added dropwise. The suspension was placed in a 50 ˚C bath and stirred 15 min. The heating bath was removed and the suspension allowed to cool back to ambient temperature over 30 min. Morpholine (0.065 mL, 0.73 mmol) was then added as a neat liquid and the mixture stirred 15 min at ambient temperature. The reaction flask was placed in an ice-bath and stirred 15 min to equilibrate. Methyl benzoate (0.082 mL, 0.66 mmol) was added dropwise as a neat liquid, and the reaction was stirred for 1 h in the ice bath. MeOH (1 mL) was added to quench the reaction. The mixture was poured directly onto a short plug of silica gel using EtOAc washes (5 ¥ 5 mL) for elution. The combined extracts were concentrated, and the residual green oil was chromatographed [Chromatotron radial chromatography, silica gel, elution solvent EtOAc-hexanes (1:5)]. The combined eluent was concentrated to provide 0.126 g of a clear, colorless oil (ca. 99% yield). ¹H NMR (300 MHz, CDCl3): δ = 3.33 (br s, 4 H), 3.59 (br s, 4 H), 7.387.46 (m, 5 H). ¹³C NMR (75 MHz, CDCl3): δ = 40.31, 66.04, 126.97, 128.41, 129.55, 135.57, 166.90. MS: m/z = 192 [M+].

19

Most of the products are simple amides previously described in the literature and/or commercially available. Thus, products were characterized by NMR (¹H, ¹³C) and MS comparing data to authentic samples or data acquired from the literature.
Selected Examples with Data
N -Benzylbenzamide (4b)
¹H NMR (300 MHz, CDCl3): δ = 4.48 (d, 2 H, J = 6.02 Hz), 7.23 (m, 1 H), 7.31 (m, 4 H), 7.51 (m, 3 H), 7.88 (m, 2 H), 9.04 (t, 1 H, J = 5.70 Hz). ¹³C NMR (75 MHz, CDCl3): δ = 42.59, 126.73, 127.19, 127.25, 128.29, 128.33, 131.26, 134.33, 139.72, 166.19. MS: m/z = 212 [M+].²0a
(4-Bromophenyl)(morpholino)methanone (4e)
¹H NMR (300 MHz, CDCl3): δ = 2.49 (br s, 4 H), 3.58 (br s, 4 H), 7.36 (d, 2 H, J = 8.68), 7.64 (d, 2 H, J = 8.58). ¹³C NMR (75 MHz, CDCl3): δ = 66.03, 122.99, 129.29, 131.47, 134.75, 168.09.²0b
(4-Methoxyphenyl)(morpholino)methanone (4f)
¹H NMR (300 MHz, CDCl3): δ = 3.48 (br s, 4 H), 3.82 (br s, 4 H), 3.79 (s, 3 H), 6.98 (d, 2 H, J = 6.68 Hz), 7.38 (d, 2 H, J = 6.76). ¹³C NMR (75 MHz, CDCl3): δ = 55.25, 66.11, 113.66, 127.47, 129.13, 160.24, 169.02. MS: m/z = 206 [M+].²0c
Morpholino(pyridin-3-yl)methanone (4h)
¹H NMR (300 MHz, CDCl3): δ = 3.64 (br s, 8 H), 7.49 (m, 1 H), 7.85 (m, 1 H), 8.64 (m, 2 H). ¹³C NMR (75 MHz, CDCl3): δ = 66.04, 123.59, 131.48, 134.96, 147.76, 150.55, 166.90. MS: m/z = 192 [M+].²0d